Seth E. Cockrum

Seth E. Cockrum

ID: 1b83c153-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

Celltrion Seeks Joinder with Pfizer IPR Challenging Rituximab-Related Patent

Biosimilars Law Bulletin · May 18, 2018

FDA Approves Retacrit as a Biosimilar to Epogen®

Biosimilars Law Bulletin · May 15, 2018

District Court Grants Genentech’s Motions to Dismiss Celltrion’s Declaratory Judgment Actions in Herceptin® and Rituxan®-Related Suits

Biosimilars Law Bulletin · May 11, 2018

Sandoz Receives Complete Response Letter from FDA for Proposed Rituximab Biosimilar

Biosimilars Law Bulletin · May 7, 2018

Final Judgment Entered in <i>Amgen v. Coherus</i> Neulasta Litigation

Biosimilars Law Bulletin · April 26, 2018

Practice Areas

Health Care and Life Sciences

Jurisdictions

Washington, D.C.